JP2022542829A5 - - Google Patents

Info

Publication number
JP2022542829A5
JP2022542829A5 JP2022502942A JP2022502942A JP2022542829A5 JP 2022542829 A5 JP2022542829 A5 JP 2022542829A5 JP 2022502942 A JP2022502942 A JP 2022502942A JP 2022502942 A JP2022502942 A JP 2022502942A JP 2022542829 A5 JP2022542829 A5 JP 2022542829A5
Authority
JP
Japan
Prior art keywords
raav
domain
cis
associated virus
relative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022502942A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022542829A (ja
Filing date
Publication date
Priority claimed from US16/512,051 external-priority patent/US10653731B1/en
Application filed filed Critical
Publication of JP2022542829A publication Critical patent/JP2022542829A/ja
Publication of JP2022542829A5 publication Critical patent/JP2022542829A5/ja
Pending legal-status Critical Current

Links

JP2022502942A 2019-07-15 2020-03-12 改善されたパッケージング効率を有する組換え改変アデノ随伴ウイルス Pending JP2022542829A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16/512,051 2019-07-15
US16/512,051 US10653731B1 (en) 2019-07-15 2019-07-15 Recombinantly-modified adeno-associated virus (rAAV) having improved packaging efficiency
PCT/US2020/022326 WO2021011034A1 (en) 2019-07-15 2020-03-12 Recombinantly-modified adeno-associated virus (raav) having improved packaging efficiency

Publications (2)

Publication Number Publication Date
JP2022542829A JP2022542829A (ja) 2022-10-07
JP2022542829A5 true JP2022542829A5 (enExample) 2023-03-16

Family

ID=70736392

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022502942A Pending JP2022542829A (ja) 2019-07-15 2020-03-12 改善されたパッケージング効率を有する組換え改変アデノ随伴ウイルス

Country Status (7)

Country Link
US (2) US10653731B1 (enExample)
EP (1) EP3999648A4 (enExample)
JP (1) JP2022542829A (enExample)
KR (1) KR20220034214A (enExample)
CN (1) CN114375337A (enExample)
AU (1) AU2020315513A1 (enExample)
WO (1) WO2021011034A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10653731B1 (en) 2019-07-15 2020-05-19 Vigene Biosciences Inc. Recombinantly-modified adeno-associated virus (rAAV) having improved packaging efficiency
US20240263143A1 (en) * 2023-02-02 2024-08-08 Agathos Biologics Baby Hamster Kidney (BHK) Cells Transformed with the Adenoviral E1 Gene for Production of Recombinant Adeno-Associated Virus

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6342390B1 (en) 1994-11-23 2002-01-29 The United States Of America As Represented By The Secretary Of Health And Human Services Lipid vesicles containing adeno-associated virus rep protein for transgene integration and gene therapy
US6093570A (en) 1995-06-07 2000-07-25 The University Of North Carolina At Chapel Hill Helper virus-free AAV production
WO1998011244A2 (en) 1996-09-11 1998-03-19 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Aav4 vector and uses thereof
US6566118B1 (en) 1997-09-05 2003-05-20 Targeted Genetics Corporation Methods for generating high titer helper-free preparations of released recombinant AAV vectors
US6989264B2 (en) 1997-09-05 2006-01-24 Targeted Genetics Corporation Methods for generating high titer helper-free preparations of released recombinant AAV vectors
US6642051B1 (en) * 1997-10-21 2003-11-04 Targeted Genetics Corporation Amplifiable adeno-associated virus(AAV) packaging cassettes for the production of recombinant AAV vectors
IT1297074B1 (it) 1997-11-21 1999-08-03 Angeletti P Ist Richerche Bio Forme ormone-dipendenti delle proteine rep del virus adeno-associato (aav-2), sequenze di dna codificanti per esse, vettori che le
WO1999061601A2 (en) 1998-05-28 1999-12-02 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Aav5 vector and uses thereof
US6984517B1 (en) 1998-05-28 2006-01-10 The United States Of America As Represented By The Department Of Health And Human Services AAV5 vector and uses thereof
US6759237B1 (en) 1998-11-05 2004-07-06 The Trustees Of The University Of Pennsylvania Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same
US6759050B1 (en) 1998-12-03 2004-07-06 Avigen, Inc. Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith
DE19905501B4 (de) 1999-02-10 2005-05-19 MediGene AG, Gesellschaft für molekularbiologische Kardiologie und Onkologie Verfahren zur Herstellung eines rekombinanten Adeno-assoziierten Virus, geeignete Mittel hierzu sowie Verwendung zur Herstellung eines Arzneimittels
US6498244B1 (en) 1999-05-28 2002-12-24 Cell Genesys, Inc. Adeno-associated virus capsid immunologic determinants
US7115391B1 (en) 1999-10-01 2006-10-03 Genovo, Inc. Production of recombinant AAV using adenovirus comprising AAV rep/cap genes
US7208315B2 (en) 2000-01-05 2007-04-24 Fred Hutchinson Cancer Research Center Compositions and methods for efficient AAV vector production
WO2002053703A2 (en) 2001-01-05 2002-07-11 Children's Hospital, Inc. Aav2 vectors and methods
US6841357B1 (en) 2001-03-30 2005-01-11 Stratagene California Method and kits for titering adeno-associated virus vectors
US6723551B2 (en) 2001-11-09 2004-04-20 The United States Of America As Represented By The Department Of Health And Human Services Production of adeno-associated virus in insect cells
WO2003042361A2 (en) 2001-11-09 2003-05-22 Government Of The United States Of America, Department Of Health And Human Services Production of adeno-associated virus in insect cells
MX359371B (es) * 2001-11-13 2018-09-25 Univ Pennsylvania Un metodo para detectar y/o identificar secuencias del virus adeno-asociado y aislamiento de secuencias novedosas identificadas de ese modo.
PT1453547T (pt) 2001-12-17 2016-12-28 Univ Pennsylvania Sequências do vírus adeno-associado (aav) do serotipo 8, vetores contendo as mesmas, e utilizações destas
US7419817B2 (en) 2002-05-17 2008-09-02 The United States Of America As Represented By The Secretary Department Of Health And Human Services, Nih. Scalable purification of AAV2, AAV4 or AAV5 using ion-exchange chromatography
US7122348B2 (en) 2002-12-11 2006-10-17 City Of Hope AAV2 Rep protein fusions
US9441244B2 (en) 2003-06-30 2016-09-13 The Regents Of The University Of California Mutant adeno-associated virus virions and methods of use thereof
US9233131B2 (en) 2003-06-30 2016-01-12 The Regents Of The University Of California Mutant adeno-associated virus virions and methods of use thereof
EP2345731B1 (en) 2003-09-30 2015-10-21 The Trustees of the University of Pennsylvania Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses thereof
US7625570B1 (en) 2005-03-10 2009-12-01 The Regents Of The University Of California Methods for purifying adeno-associated virus
EP2311966A3 (en) 2005-10-20 2012-09-05 Amsterdam Molecular Therapeutics (AMT) B.V. Improved AAV vectors produced in insect cells
WO2008024998A2 (en) 2006-08-24 2008-02-28 Virovek, Inc. Expression in insect cells of genes with overlapping open reading frames, methods and compositions therefor
WO2010022195A2 (en) 2008-08-20 2010-02-25 Virxsys Corporation Non-integrating lenti/adeno-associated virus hybrid vector system
KR20180000341A (ko) 2009-06-16 2018-01-02 젠자임 코포레이션 재조합 aav 벡터에 대한 개선된 정제 방법
BR112012010755A2 (pt) * 2009-11-05 2015-09-22 Proyecto Biomedicina Cima Sl constructo de gene que permite a expressão hepato-específica induzível de um polinucleotídeo de interesse em resposta a um agente indutor, vetor, genoma viral recombinante, vírion, método in vitro para a expressão de um polinucleotídeo de interesse em uma célula de origem hepática, composição farmacêutica e operador-promotor bi-direcional induzível adequado para a expressão hepato-específica induzível de dois polinucleotídeos de interesse por um agente indutor
US8663624B2 (en) 2010-10-06 2014-03-04 The Regents Of The University Of California Adeno-associated virus virions with variant capsid and methods of use thereof
TR201908020T4 (tr) 2011-02-17 2019-06-21 Univ Pennsylvania Doku özgüllüğünü değiştirmek ve aav9-aracılı gen transferini geliştirmek için bileşimler ve yöntemler.
EP2500434A1 (en) 2011-03-12 2012-09-19 Association Institut de Myologie Capsid-free AAV vectors, compositions, and methods for vector production and gene delivery
US20140155469A1 (en) 2011-04-19 2014-06-05 The Research Foundation Of State University Of New York Adeno-associated-virus rep sequences, vectors and viruses
CN105755044A (zh) 2011-04-22 2016-07-13 加利福尼亚大学董事会 具有变异衣壳的腺相关病毒病毒体及其使用方法
CA2853482C (en) 2011-10-28 2020-05-19 Joshua Grieger Cell line for production of adeno-associated virus
AU2013266968B2 (en) 2012-05-25 2017-06-29 Emmanuelle CHARPENTIER Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US8697359B1 (en) 2012-12-12 2014-04-15 The Broad Institute, Inc. CRISPR-Cas systems and methods for altering expression of gene products
WO2014093965A1 (en) * 2012-12-14 2014-06-19 Case Western Reserve University Genomic rna packaging enhancer element
WO2014143932A1 (en) 2013-03-15 2014-09-18 The University Of North Carolina At Chapel Hill Synthetic adeno-associated virus inverted terminal repeats
CN105765066B (zh) 2013-11-29 2018-12-14 宝生物工程株式会社 用于定量腺伴随病毒的方法
GB201407852D0 (en) * 2014-05-02 2014-06-18 Iontas Ltd Preparation of libraries od protein variants expressed in eukaryotic cells and use for selecting binding molecules
EP3368692B1 (en) * 2015-10-29 2021-07-21 Temple University Of The Commonwealth System Of Higher Education Modification of 3' terminal ends of nucleic acids by dna polymerase theta
WO2017112948A1 (en) 2015-12-24 2017-06-29 University Of Florida Research Foundation, Inc. Improved aav production using suspension adapted cells
CN108884446A (zh) * 2016-01-29 2018-11-23 西里昂生物技术有限责任公司 基于aav的条件表达系统
MX2018014256A (es) * 2016-05-20 2019-08-16 Harvard College Metodos de terapia genica para enfermedades y condiciones relacionadas con la edad.
US10294452B2 (en) 2016-11-22 2019-05-21 Dao-Yao He Lysis, extraction and purification of adeno-associated virus and adenovirus from host cells
CN108727486A (zh) * 2017-04-24 2018-11-02 舒泰神(北京)生物制药股份有限公司 长效神经生长因子、制备方法及其组合物
US10653731B1 (en) * 2019-07-15 2020-05-19 Vigene Biosciences Inc. Recombinantly-modified adeno-associated virus (rAAV) having improved packaging efficiency

Similar Documents

Publication Publication Date Title
JP6619454B2 (ja) キャプシド
US7220577B2 (en) Modified AAV
ES2288037T3 (es) Secuencia de acido nucleico del serotipo 1 de adenovirus asociado, vectores y celulas huesped que las contienen.
ES2230569T3 (es) Funciones accesorias para uso en la produccion de viriones aav recombinantes.
US7186552B2 (en) Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same
CN103849629B (zh) 具有经修饰的用于在昆虫细胞中产生aav的aav‑rep78翻译起始密码子的载体
ES2751919T3 (es) Impurezas de ADN en una composición que comprende un virión parvoviral
CN110997912A (zh) 用于改进的细胞转染和/或rAAV载体生产的增强剂
US20110171262A1 (en) Parvoviral capsid with incorporated gly-ala repeat region
CN101868547A (zh) 包含具有差别密码子偏性的重复编码序列的杆状病毒载体
CN106884014B (zh) 腺相关病毒反向末端重复序列突变体及其应用
TW202246516A (zh) 病毒蛋白之控制表現
CN111876432B (zh) 一组肝靶向新型腺相关病毒的获得及其应用
JP2022542828A5 (enExample)
JP2024533174A (ja) Aavカプシド組成物及び送達方法
JP2022542829A5 (enExample)
JP2023529371A5 (enExample)
JP2024534897A (ja) Aavカプシド組成物及び送達方法
AU2013254897B2 (en) Vectors with modified initiation codon for the translation of AAV-Rep78 useful for production of AAV in insect cells
CN118955653A (zh) 腺相关病毒衣壳蛋白的突变体、编码其的核酸及应用
HK40020047A (en) Capsid
BR112016005576B1 (pt) Vetor de fator viii de vírus adeno-associado, partícula de vírus adeno-associado recombinante, partícula viral, uso do referido vetor ou da referida partícula viral para o tratamento de hemofilia a e método para produzir uma partícula de vírus adeno-associado